NGUY CƠ TIM MẠCH TRONG VÒNG 10 NĂM Ở NGƯỜI BỆNH VIÊM KHỚP VẨY NẾN

Abstract

Objectives: To assess the 10-year cardiovascular risk in patients with psoriatic arthritis (PsA) according to the recommendations of the Vietnam National Heart Association.To investigate the association between cardiovascular risk and certain clinical and paraclinical characteristics in this patient population. Methods: A cross-sectional descriptive study was conducted. The study population included 30 patients diagnosed with psoriatic arthritis based on the CASPAR criteria (2006), who were examined at Bach Mai Hospital from August 2024 to July 2025. Results: The proportions of patients with low–moderate, high, and very high cardiovascular risk were 40%, 26.7%, and 33.3%, respectively. Patients in the high–very high risk group had a higher mean age (54.4 ± 10.1 vs. 48.9 ± 6.6 years; p = 0.004), longer disease duration (5.8 ± 6.5 vs. 3.1 ± 2.7 years; p = 0.048), a higher proportion of males (94.4% vs. 50%; p = 0.001), increased CRP levels (66.7% vs. 33.3%; p = 0.032), higher disease activity (61.1% vs. 25%; p = 0.043), and a greater use of conventional DMARDs (72.2% vs. 50%; p = 0.039) compared to the low–moderate risk group. Conclusions:Most patients with psoriatic arthritis had high to very high cardiovascular risk. Factors associated with elevated cardiovascular risk in PsA patients included age, male gender, disease duration, CRP levels, disease activity, and treatment regimen. Regular assessment of cardiovascular risk should be integrated into the routine management of PsA patients.